| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Elekta AB, headquartered in Stockholm, Sweden, offers clinical solutions and
services for the radiation treatment of cancer and the minimally-invasive
treatment of brain disorders, including tumours, vascular disorders and
functional disorders such as facial pain, epilepsy and Parkinson's disease.
This report provides a full review of the company's activities.
Elekta operates within two business areas, oncology and neurosurgery. The
company's main business is oncology, sales of which increased by 16% to SKr
2.2 billion in 2005. Elekta claims to be the world's second-largest supplier
of oncology products after Varian Medical Systems. It offers linear
accelerators, simulators, stereotactic radiotherapy equipment, 3D dose
planning systems and products for intensity-modulated radiation treatment. In
April 2005, Elekta acquired Impac Medical Systems, enabling Elekta to also
offer a range of medical IT systems for use in cancer care, including
integrated solutions centred on image-enabled electronic medical records
covering the cancer treatment process.
Elekta claims to be the market leader for devices for the radiosurgical
treatment of brain disorders as a result of its Leksell Gamma Knife
technology. The company's neurosurgery products also include the
magnetoencephalography devices gained through the 2003 acquisition of
Neuromag. In 2005, neurosurgery sales declined by 5% to SKr 977 million.
In fiscal 2005, Elekta's revenue rose by 9% to SKr 3.2 billion.
This report provides a complete review of the company's activities, from its
origins to its latest corporate activity, including mergers and acquisitions,
agreements, divestitures, major purchasing contracts and litigation. Sections
are included on products, international activities and R&D, as well as a full,
in-depth five year financial analysis.
TABLE OF CONTENTS
- OVERVIEW
- CORPORATE HISTORY
- FOUNDATION
- RECENT CORPORATE NEWS
- MERGERS AND ACQUISITIONS
- Impac Medical Systems
- Shanghai Elekta Oncology Systems
- Neuromag
- Philips' Radiotherapy Division
- Cordis Neuroscience
- MINORITY INVESTMENTS
- ONCOlog Medical
- Motala Verkstad
- GK Financing LLC
- DIVESTITURES
- Image-guided Surgery Business
- Elekta Surgical Instruments
- Modus Product Line
- AGREEMENTS
- Siemens Medical Solutions
- Implant Sciences
- Medical Intelligence
- Mattson Jack Group
- Coalition of Cancer Cooperative Groups
- PerkinElmer
- North American Scientific
- Axeda Systems
- Nucletron (Delft Instruments)
- Simulators
- Oncentra Oncology Management Solutions
- AerotechTelub
- 4-D Neuroimaging
- Philips Medical Systems
- IMRT Systems
- Radiation Oncology
- Eastman Kodak
- Nexus
- SUPPLY AGREEMENTS
- West Clinic
- Providence Health System
- INVAP
- Centre Hospitalier de Rodez
- University of Pittsburgh Medical Center
- Seoul National University
- St. James' Hospital, UK
- Premier Purchasing Partners
- Consorta
- Catholic Health East
- HealthTrust Purchasing Group
- Broadlane
- Oncology Products
- Radiosurgery Products
- MedAssets HSCA
- Joint Purchasing Corporation
- LITIGATION
- 4-D Neuroimaging
- CORPORATE STRUCTURE
- STRATEGIC FOCUS
- Improving International Sales
- The American Market
- The European Market
- The Asian Market
- Japan
- Enhance Service Operations
- PRODUCTS
- ONCOLOGY SYSTEMS
- Elekta Synergy
- 4D Adaptive IGRT
- Elekta Synergy S
- Elekta IntelliMax
- Elekta Precise Solutions
- Intensity Modulated Radiation Therapy (IMRT)
- PreciseBEAM
- EPinnaclePRO
- Planning and Simulation
- ACQSim CT Scanner
- PreciseSIM
- Treatment and Verification
- DesktopPro
- Precise Table
- PreciseNET
- Precise Digital Accelerator
- MLCi
- Beam Modulator
- Active Breathing Co-ordinator
- Stereotactic Body Frame
- iView Guided Therapy (iViewGT)
- IMPAC PRODUCTS
- IQ Platform
- Practice Management
- Electronic Charting
- Radiation Oncology Charting
- Medical Oncology Charting
- Medical Oncology Laboratory Management
- IntelliLab
- Radiation Treatment Verification
- Image Management for Medical and Radiation Oncology
- ESI Data Interchange
- National Oncology DataBase
- NEUROSURGERY
- Leksell Gamma Knife Surgery Products
- Leksell Gamma Knife 4C
- Leksell GammaPlan 4C
- Leksell Gamma Knife C
- Leksell GammaPlan
- Leksell GammaPlan Wizard
- Gamma FastSite
- Stereotactic Neurosurgery
- Leksell Stereotactic System
- Leksell SurgiPlan
- AtlasSpace
- Leksell Neuro Generator
- MR Phantom
- Stereotactic Guide
- Magnetoencephalography Products
- Elekta Neuromag
- Neuromag Vectorview Software
- Vectorview
- INTERNATIONAL ACTIVITIES
- EUROPE
- Finland
- United Kingdom
- THE AMERICAS
- United States
- South America
- ASIA
- China
- Japan
- Australia
- Average Number Of Employees 2004-2005
- GLOBAL LOCATIONS
- RESEARCH AND DEVELOPMENT
- RESEARCH ESTABLISHMENTS
- RESEARCH PROJECTS
- Synergistiq
- RESEARCH AGREEMENTS
- University of California San Diego
- IMRT International Consortium
- Intensity-Modulated Arc Therapy
- Gel Dosimetry
- FINANCIAL REVIEW
- FINANCIAL INDICATORS
- FINANCIAL HIGHLIGHTS
- COMMENTARY
- First Quarter of Fiscal 2006
- OUTLOOK
- FISCAL 2005
- Product Categories
- Revenue by Product Area, 2002-2005 (SKr million)
- Order Bookings by Product Area, 2002-2005 (SKr million)
- Global Review
- The Americas
- Europe, the Middle East and Africa
- Japan
- Asia Excluding Japan
- Revenue by Country of Origin, 2002-2005 (SKr million)
- Order Bookings by Country of Origin, 2002-2005 (SKr million)
- Assets at 30th April by Region, 2004-2005 (SKr million)
INDEX OF TABLES
- Average Number Of Employees 2004-2005
- Revenue by Product Area, 2002-2005 (SKr million)
- Order Bookings by Product Area, 2002-2005 (SKr million)
- Revenue by Country of Origin, 2002-2005 (SKr million)
- Order Bookings by Country of Origin, 2002-2005 (SKr million)
- Assets at 30th April by Region, 2004-2005 (SKr million)
INDEX OF CHARTS
- Fig.1: Percentage of Revenue by Product Area, 2005
- Fig.2: Percentage of Order Bookings by Product Area, 2005
- Fig.3: Percentage of Revenue by Geographic Market, 2005
- Fig.4: Percentage of Orders by Geographic Market, 2005
- Fig.5: Assets at 30th April 2005 by Geographic Market, 2005
|
